HDAC Inhibition in Vascular Endothelial Cells Regulates the Expression of ncRNAs
While clinical and pre-clinical trials indicate efficacy of histone deacetylase (HDAC) inhibitors in disease mediated by dynamic lysine modification, the impact on the expression of non-coding RNAs (ncRNAs) remains poorly understood. In this study, we investigate high throughput RNA sequencing data...
Main Authors: | Haloom Rafehi, Assam El-Osta |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2016-05-01
|
Series: | Non-Coding RNA |
Subjects: | |
Online Access: | http://www.mdpi.com/2311-553X/2/2/4 |
Similar Items
-
Systems approach to the pharmacological actions of HDAC inhibitors reveals EP300 activities and convergent mechanisms of regulation in diabetes
by: Haloom Rafehi, et al.
Published: (2017-11-01) -
Epigenetic Regulatory Dynamics in Models of Methamphetamine-Use Disorder
by: Subramaniam Jayanthi, et al.
Published: (2021-10-01) -
Emerging Role of Epigenetic Modifiers in Breast Cancer Pathogenesis and Therapeutic Response
by: Richard Sean Lee, et al.
Published: (2023-08-01) -
Histone modification of endothelial-mesenchymal transition in cardiovascular diseases
by: Qiu Jun, et al.
Published: (2022-12-01) -
Epigenetic control of the vicious cycle
by: Madeline B. Searcy, et al.
Published: (2024-02-01)